NDC 63629-1926-01 - OXYMORPHONE HYDROCHLORIDE
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 63629-1926
- Requested NDC
- 63629-1926-01
- Package NDCs from labels
- 63629-1926-1, 63629-1926-01
- Manufacturer
- Bryant Ranch Prepack
- Effective date
- 2024-01-09
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| OXYMORPHONE HYDROCHLORIDE - Bryant Ranch Prepack | Bryant Ranch Prepack | 2024-01-09 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 63629-1926-1 | OXYMORPHONE HYDROCHLORIDE | 100 in 1 BOTTLE | TABLET | 100 | 102 |
DailyMed Dashboard NDC Coverage#
| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|---|---|---|---|
| 63629-1926 | OXYMORPHONE HYDROCHLORIDE TABLET [BRYANT RANCH PREPACK] | 102 | Current NDC, Legacy NDC, 1 package rows | 20240110_560e9425-dfcb-4fb4-a759-b1e3f8f40fdb.zip |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 63629-1926-1 | EA - Each | 63629-1926 | 650c7df6-ef2f-465c-b1c5-8321ee403024 | 1 | 2021-03-02 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | Aurolife Pharma, LLC | 22c7652a-aa16-4fa8-89d9-517e69059068 | 2026-06-29 | Boxed warning, Warnings, Adverse reactions | 977942 977939 5Y2EI94NBC |
| Caldesene Baby | STARCH, CORN AND ZINC OXIDE | Insight Pharmaceuticals LLC | 9f12dee2-7afa-45e9-a729-0fd42bb77715 | 2026-04-22 | Warnings | O8232NY3SJ |
| Caldesene Medicated Protecting | CORNSTARCH AND ZINC OXIDE | Insight Pharmaceuticals LLC | ffc92a0f-a7cf-4a46-b2f1-089df2bbb96b | 2026-04-22 | Warnings | O8232NY3SJ |
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | KVK-Tech, Inc. | dcb5b5d2-7d0a-497a-8f1e-3b96fd43320b | 2026-01-30 | Boxed warning, Warnings, Adverse reactions | 977942 977939 5Y2EI94NBC |
| Lotrimin Daily Sweat and Odor Control | TOPICAL STARCH | Bayer HealthCare LLC. | 9ec5c80d-b550-496f-e053-2a95a90a5489 | 2026-01-16 | Warnings | O8232NY3SJ |
| Oxymorphone hydrochloride | OXYMORPHONE HYDROCHLORIDE | Amneal Pharmaceuticals LLC | 3f4e703a-e398-42fd-8759-e398c79955f1 | 2026-01-15 | Boxed warning, Warnings, Adverse reactions | 5Y2EI94NBC |
| Medicated Cornstarch Baby Powder | ACTIVE CORN STARCH | Davion, Inc. | e39032d1-c8cd-4a41-af10-126970b8ad38 | 2025-12-29 | Warnings | O8232NY3SJ |
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | Epic Pharma, LLC | 95804e72-232d-425d-b23d-a66f43bdf0c6 | 2025-12-15 | Boxed warning, Warnings, Adverse reactions | 977942 977939 5Y2EI94NBC |
| Oxymorphone Hydrochloride | OXYMORPHONE HYDROCHLORIDE | Hikma Pharmaceuticals USA Inc. | 3eb971cf-ab82-49f3-a46c-4d76a8ce599e | 2025-12-12 | Boxed warning, Warnings, Adverse reactions | 977942 977939 5Y2EI94NBC |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | Camber Pharmaceuticals, Inc | 06af7dff-c261-4c03-9cd9-0605c42507fa | 2025-08-18 | Boxed warning, Warnings, Adverse reactions | ANDA210175 31722-929 977942 977939 53da63d9-6ef9-4feb-b704-5b7ef1785f6c 06af7dff-c261-4c03-9cd9-0605c42507fa 5Y2EI94NBC |
| YVTYVT MICRODERMABRASION FACIAL SCRUB | YVTYVT MICRODERMABRASION FACIAL SCRUB | Beijing JUNGE Technology Co., Ltd. | 2f30fc45-42e2-c766-e063-6394a90a8d68 | 2025-02-28 | Warnings | OP1R32D61U |
| Pure Cornstarch Baby | CORN STARCH | Walgreen Company | d0e9bd13-b568-4f7e-b036-8d23e71ad8bf | 2024-03-25 | Warnings | O8232NY3SJ |
| Oxymorphone hydrochloride | OXYMORPHONE HYDROCHLORIDE | Amneal Pharmaceuticals of New York LLC | 557e9610-62d7-42bf-90c1-44215bd8c1f8 | 2024-01-10 | Boxed warning, Warnings, Adverse reactions | 5Y2EI94NBC |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | Bryant Ranch Prepack | 560e9425-dfcb-4fb4-a759-b1e3f8f40fdb | 2024-01-09 | Boxed warning, Warnings, Adverse reactions | ANDA210175 63629-1926-1 63629-1926 63629192601 977939 c58a9e13-1792-4569-a677-28d9aaf0c9f0 560e9425-dfcb-4fb4-a759-b1e3f8f40fdb 5Y2EI94NBC |
| OXYMORPHONE HYDROCHLORIDE | OXYMORPHONE HYDROCHLORIDE | XLCare Pharmaceuticals, Inc. | 1a1d5061-b62a-49fa-a5b2-4970f51416ae | 2020-05-07 | Boxed warning, Warnings, Adverse reactions | ANDA210175 977942 977939 5Y2EI94NBC |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.